Gregory Schafer Insider Profile
4 Followers
Gregory Schafer, Director at Capricor Therapeutics, holds 0.00 shares in Capricor Therapeutics (Ticker: CAPR), holds 254.06K shares in Chinook Therapeutics (Ticker: KDNY), holds 0.00 shares in Onyx Pharma (Ticker: ONXX).
Gregory Schafer's Trading History
| KDNYChinook Therapeutics | Sep 14, 2017 | ― | Uninformative Buy | ― | $10.26M | |
| ONXXOnyx Pharma | ― | ― | ― | ― | ||
| CAPRCapricor Therapeutics | ― | Director | ― | $0.00 |
You May Also Like
Gregory Schafer insider profile FAQ
What is the percentage of profitable transactions made by Gregory Schafer?
The percentage of profitable transactions made by Gregory Schafer is 50%.
What is the average return per transaction made by Gregory Schafer?
The average return per transaction made by Gregory Schafer is -10.40%.
What stocks does Gregory Schafer hold?
Gregory Schafer holds: CAPR, KDNY, ONXX stocks.
What was Gregory Schafer's most profitable transaction?
Gregory Schafer’s most profitable transaction was an Informative Sell of KDNY stock on September 14, 2017. The return on the trade was 39.70%.
What is Gregory Schafer's role in Capricor Therapeutics?
Gregory Schafer's role in Capricor Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
